Chronic hepatitis B. Hope for decreasing its impact.
Although chronic hepatitis B is a relatively common disease that may have a serious outcome, the outlook is by no means uniformly poor. Alpha interferon therapy may be helpful in up to one third of patients who have hepatitis B e antigen in serum and elevated serum aminotransferase levels. New drugs that may have even better results are being developed. Hepatitis B may be prevented by large-scale use of hepatitis B vaccine. National vaccination programs may eventually eliminate or at least substantially decrease the impact of this viral infection.